封面
市场调查报告书
商品编码
1410786

胰岛素笔市场:市场规模(按细分市场)、份额、监管、报销、预测(~2033 年)

Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

出版日期: | 出版商: GlobalData | 英文 | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

胰岛素笔用于注射胰岛素以治疗糖尿病。它由胰岛素筒(一体式或单独出售)和用于测量剂量的刻度盘组成,并与一次性笔针一起使用来管理剂量。

胰岛素笔分为一次性胰岛素笔和重复使用型胰岛素笔。一次性胰岛素笔通常由预先填充的胰岛素药筒组成,一旦小瓶用完,胰岛素药筒就会被丢弃。对于可重复使用的胰岛素笔,用完后可以更换笔芯。

本报告深入探讨了全球胰岛素笔市场,包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。

目录

目前市面上胰岛素笔及竞争状况

  • 洞察关键产业趋势
  • 2015年至2033年胰岛素笔各细分市场的市场总收入及市场前景
  • 按细分市场划分的程序总数、单位数、平均售价和市场价值的详细数据

全球、区域和国家见解

  • 胰岛素笔市场的SWOT分析
  • 胰岛素笔市场的竞争动态洞察与趋势
  • 按国家/地区划分的医疗保健系统概览
  • 各国报销政策
  • 各国医疗技术法规现状

Abstract

Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within Diabetes Care Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Insulin Pens Devices market for the year 2020 and beyond. Insulin pen is used to inject insulin for the treatment of diabetes. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose.

Insulin pens are classified into disposable and reusable insulin pens. Disposable insulin pens usually consist of pre-filled insulin cartridge which is disposed once the vial is over. In case of reusable insulin pens, the cartridge can be replaced once it is over.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Insulin Pens Devices and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Insulin Pens Devices market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Insulin Pens Devices market.
  • Competitive dynamics insights and trends provided for Insulin Pens Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Novo Nordisk AS, Eli Lilly and Co, Sanofi, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Insulin Pens marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Insulin Pens market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Insulin Pens market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Insulin Pens market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Insulin Pens market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable